Showing results (71-80 of 180) with videos related to

Sort By:
Pageof 18
Acta Psychiatrica Scandinavica|December 1, 1987
Clonazepam/haloperidol combination therapy in schizophrenia: a double blind studyA C Altamura, M C Mauri, M Mantero, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 15, 2001
The 5HT1Dbeta receptor gene in bipolar disorder: a family-based association studyE Mundo, G Zai, L Lee, et al.
The American Journal of Psychiatry|June 30, 2000
Is the 5-HT(1Dbeta) receptor gene implicated in the pathogenesis of obsessive-compulsive disorder?E Mundo, M A Richter, F Sam, et al.
Clinical Neuropharmacology|January 1, 1990
Alternative prophylactic treatments to lithium in bipolar disordersM C Mauri, M Percudani, M G Regazzetti, et al.
Psychopharmacology|January 1, 1985
Early unwanted effects of fluphenazine esters related to plasma fluphenazine concentrations in schizophrenic patientsA C Altamura, S H Curry, S Montgomery, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1987
Plasma and brain pharmacokinetics of mianserin after single and multiple dosing in miceA C Altamura, F De Novellis, M C Mauri, et al.
Clinical Neuropharmacology|February 15, 2017
The Use of Zonisamide for the Treatment of Psychiatric Disorders: A Systematic ReviewMassimiliano Buoli, Silvia Grassi, Valentina Ciappolino, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1987
Fluphenazine decanoate in acute and maintenance therapy of schizophreniaA C Altamura, M C Mauri, G Guercetti, et al.
Minerva Psichiatrica|January 1, 1991
[L-sulpiride in the treatment of somatoform disturbances: a double-blind study with racemic sulpiride]A C Altamura, M C Mauri, G Regazzetti, et al.
Psychopharmacology|January 1, 1983
Age-related differences in kinetics and side-effects of viloxazine in man and their clinical implicationsA C Altamura, T Melorio, G Invernizzi, et al.
Pageof 18